Mastocytosis - 30 Studies Found

Completed : Efficacy and Safety of TF002 in Cutaneous Mastocytosis
: Cutaneous Mastocytosis
: 2007-04-04
: Drug: TF 002
Completed : Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
:
  • Urticaria Pigmentosa
  • Cutaneous Mastocytosis

: 2016-03-15
:
  • Other: skin biopsy A skin biop
Completed : A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
:
  • Smouldering Systemic Mastocytosis
  • Indolent Systemic Mastocytosis
  • Drug: masitinib (AB1010) masit
Terminated : Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
:
  • Malignant Mast Cell Tumors
  • Solid Organ Sites

: 2012-06-07
: Other: QUALITY OF LIFE QUESTIONNAIRE QASICC AND EORTC QLQ-C30 ADMINISTRATION 30 DAYS AFTER CVC IMPLANTAT
Completed : Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
: Systemic Mastocytosis
: 2015-05-05
: Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera
Completed : Natural History of Urticaria Pigmentosa in Children
: Urticaria Pigmentosa
: 2007-04-30
Completed : Mast Cell Connect: A Registry for Patients With Mastocytosis
: Mastocytosis
: 2015-11-19
Completed : The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
: Mastocytosis
: 2009-07-20
: Drug: injections subcutaneous injections
Completed : Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
: Systemic Mastocytosis
: 2007-03-19
: Drug: RAD001 (Everolimus) Oral RAD001 10 mg daily for 30 days
Completed : Imatinib in KIT-negative Systemic Mastocytosis
: Systemic Mastocytosis
: 2011-02-16
: Drug: Imatinib Mesylate
  • In
Next >>>